![Mark Erlander](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Erlander
Keine laufenden Positionen mehr
Vermögen: 31 825 $ am 30.06.2026
Profil
Mark Erlander worked as an Assistant Professor at The Scripps Research Institute from 1991 to 1994.
From 1994 to 2000, served as Principal at Johnson & Johnson.
Held the position of Chief Scientific Officer at Arcturus Studios Holdings, Inc. between 2000 and 2008.
Worked as Chief Scientific Officer at Biotheranostics, Inc. from 2008 to 2013.
Served as Chief Scientific Officer at Gensignia Life Sciences, Inc. from 2013 to 2014.
From 2020 to 2026, was Chief Executive Officer & Director at Cardiff Oncology, Inc. Education includes a doctorate from the University of California, Los Angeles, graduate studies at Iowa State University, and undergraduate studies at the University of California, Davis.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CARDIFF ONCOLOGY, INC. 0,04 % | 20.04.2026 | 24.481 ( 0,04 % ) | 31 825 $ | 30.06.2026 |
Ehemalige bekannte Positionen von Mark Erlander
| Unternehmen | Position | Ende |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Vorstandsvorsitzender | 27.01.2026 |
Gensignia Life Sciences, Inc.
 Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which develop new molecular diagnosis techniques | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2014 |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2013 |
Arcturus Studios Holdings, Inc.
 Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Develops video editing software for live-action performances | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2008 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 01.01.2000 |
Ausbildung von Mark Erlander
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Los Angeles
 University of California, Los Angeles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iowa State University
 Iowa State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
University of California, Davis
 University of California, Davis Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gensignia Life Sciences, Inc.
Gensignia Life Sciences, Inc. BiotechnologyHealth Technology Operates as a molecular diagnostics company which develop new molecular diagnosis techniques | Health Technology |
Arcturus Studios Holdings, Inc.
Arcturus Studios Holdings, Inc. Packaged SoftwareTechnology Services Develops video editing software for live-action performances | Technology Services |
